Showing results (211-220 of 253) with videos related to
Sort By:
Pageof 26
Breast Cancer Research and Treatment|June 16, 2021
Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control studyWendy R Muñoz-Montaño, Paula Cabrera-Galeana, Cynthia De la Garza-Ramos, et al.Cancer|October 19, 2018
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trialsMatteo Lambertini, Samuel Martel, Christine Campbell, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2015
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancerAmir Sonnenblick, Prudence A Francis, Hatem A Azim, et al.ESMO Open|May 8, 2024
Equitable inclusion of diverse populations in oncology clinical trials: deterrents and driversL Vidal, Z Dlamini, S Qian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trialHatem A Azim, Dominique Agbor-Tarh, Ian Bradbury, et al.Therapeutic Advances in Medical Oncology|November 29, 2023
Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohortRasha Aboelhassan, Mohamed Emam Sobeih, Mohamed Alm El-Din, et al.Cancer Research Communications|October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing TumorsMarc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2020
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)S Paluch-Shimon, F Cardoso, A H Partridge, et al.Journal of the National Cancer Institute|April 22, 2016
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized TrialAmir Sonnenblick, Evandro de Azambuja, Dominique Agbor-Tarh, et al.JAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.Pageof 26